Carla Rothlin, PhD
Yale University, New Haven, CT
Dendritic Cells (DCs), the master regulators of the immune system, are in charge of coordinating the system’s response to invading viruses, bacteria, and other pathogens while simultaneously ignoring the body’s own proteins. Controlled regulation of the activation of these cells is crucial for normal functioning of the immune system, as their hyper-activation can lead to the reaction against “self-proteins” and the development of autoimmunity.
Describing the mechanisms that limit DC function is likely to be of fundamental significance for developing novel therapies for autoimmune diseases such as lupus. Having discovered a novel mechanism in DCs that restrains their hyper-activation, Dr. Rothlin and colleagues will now, with LRI funding, explore how this mechanism is set in motion in vivo.
The goal: to translate this knowledge into new therapeutic approaches for the treatment of lupus.
Results published in the July 25, 2013 issue of the leading biomedical journal Immunity.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms
- B Cells
- Cardiovascular System
- Cell Signaling
- Central Nervous System
- Dendritic Cells
- Environmental Triggers
- Gender Matters
- General Immune System Function
- Human Lupus Biology
- Lupus Pregnancy
- New to Lupus
- New Treatments
- T Cells
- Target Identification
- Why the Lupus Immune System Reacts to Its Own DNA